Occudo Quantitative Strategies LP Bridge Bio Pharma, Inc. Transaction History

Occudo Quantitative Strategies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $228,430 - $417,393	9,510 New	9,510 $383,000
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $269,933 - $365,801	20,311 New	20,311 $349,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $5,796 - $9,022	730 Added 3.82%	19,834 $197,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $636,109 - $1.48 Million	-122,094 Reduced 86.47%	19,104 $173,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $905,829 - $2.12 Million	123,410 Added 693.78%	141,198 $1.43 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $202,427 - $950,057	17,788 New	17,788 $297,000
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $221,158 - $288,459	-3,987 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $153,021 - $283,515	3,987 New	3,987 $284,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.